非综合征型遗传性耳聋
Rare non-syndromic genetic deafness
定义 英文原文(暂无中文)
A rare genetic deafness characterized by sensorineural, conductive, or mixed hearing loss occurring as an isolated finding, without associated malformations or abnormalities of other organ systems. Hearing impairment may range from mild to profound; onset may be prelingual or postlingual, and hearing loss may be stable or progressive. It displays marked genetic heterogeneity with autosomal recessive (DFNB; ~75-80%), autosomal dominant (DFNA; ~20%), X-linked (DFNX; ~2-5%), mitochondrial (<1%), and Y-linked (DFNY; <1%) inheritance. Autosomal recessive forms typically present with severe-to-profound congenital hearing loss, while autosomal dominant forms more commonly show progressive postlingual onset.
别名
非综合征性遗传性听力丧失
基本事实
- 遗传方式
- 常染色体显性、常染色体隐性、X 连锁隐性
- 发病年龄
- 婴儿期、新生儿期
相关基因 60来自下位疾病
Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。
| 基因 | 名称 | 来源条目 |
|---|---|---|
| ABCC1 | ATP binding cassette subfamily C member 1 (ABCC1 blood group) | ORPHA:90635 |
| ACTG1 | actin gamma 1 | ORPHA:90635 |
| ADCY1 | adenylate cyclase 1 | ORPHA:90636 |
| AFG2B | AAA ATPase AFG2B | ORPHA:90636 |
| AIFM1 | apoptosis inducing factor mitochondria associated 1 | ORPHA:139583 |
| ATP11A | ATPase phospholipid transporting 11A | ORPHA:90635 |
| BDP1 | BDP1 general transcription factor IIIB subunit | ORPHA:90636 |
| BSND | barttin CLCNK type accessory subunit beta | ORPHA:90636 |
| CABP2 | calcium binding protein 2 | ORPHA:90636 |
| CCDC50 | coiled-coil domain containing 50 | ORPHA:90635 |
| CD164 | CD164 molecule | ORPHA:90635 |
| CDC14A | cell division cycle 14A | ORPHA:90636 |
| CDH23 | cadherin related 23 | ORPHA:90636 |
| CEACAM16 | CEA cell adhesion molecule 16, tectorial membrane component | ORPHA:90635 |
| CENPP | centromere protein P | ORPHA:90635 |
| CIB2 | calcium and integrin binding family member 2 | ORPHA:90636 |
| CLDN14 | claudin 14 | ORPHA:90636 |
| CLIC5 | CLIC family member 5 | ORPHA:90636 |
| COCH | cochlin | ORPHA:90635 |
| COL11A1 | collagen type XI alpha 1 chain | ORPHA:90635 |
| COL11A2 | collagen type XI alpha 2 chain | ORPHA:90635 |
| COL4A6 | collagen type IV alpha 6 chain | ORPHA:90625 |
| CRYM | crystallin mu | ORPHA:90635 |
| DCDC2 | doublecortin domain containing 2 | ORPHA:90636 |
| DIABLO | diablo IAP-binding mitochondrial protein | ORPHA:90635 |
| DIAPH3 | diaphanous related formin 3 | ORPHA:90635 |
| DMXL2 | Dmx like 2 | ORPHA:90635 |
| ELMOD3 | ELMO domain containing 3 | ORPHA:90636 |
| EPS8 | EGFR pathway substrate 8, signaling adaptor | ORPHA:90636 |
| EPS8L2 | EPS8 signaling adaptor L2 | ORPHA:90636 |
| ESPN | espin | ORPHA:90635 |
| ESRRB | estrogen related receptor beta | ORPHA:90636 |
| EYA4 | EYA transcriptional coactivator and phosphatase 4 | ORPHA:90635 |
| GIPC3 | GIPC PDZ domain containing family member 3 | ORPHA:90636 |
| GJB2 | gap junction protein beta 2 | ORPHA:90635 |
| GJB3 | gap junction protein beta 3 | ORPHA:90635 |
| GJB6 | gap junction protein beta 6 | ORPHA:90635 |
| GPSM2 | G protein signaling modulator 2 | ORPHA:90636 |
| GRAP | GRB2 related adaptor protein | ORPHA:90636 |
| GRHL2 | grainyhead like transcription factor 2 | ORPHA:90635 |
| GRXCR1 | glutaredoxin and cysteine rich domain containing 1 | ORPHA:90636 |
| GRXCR2 | glutaredoxin and cysteine rich domain containing 2 | ORPHA:90636 |
| GSDME | gasdermin E | ORPHA:90635 |
| HGF | hepatocyte growth factor | ORPHA:90636 |
| HOMER2 | homer scaffold protein 2 | ORPHA:90635 |
| ILDR1 | immunoglobulin like domain containing receptor 1 | ORPHA:90636 |
| KARS1 | lysyl-tRNA synthetase 1 | ORPHA:90636 |
| KCNQ4 | potassium voltage-gated channel subfamily Q member 4 | ORPHA:90635 |
| KITLG | KIT ligand | ORPHA:90635 |
| LHFPL5 | LHFPL tetraspan subfamily member 5 | ORPHA:90636 |
| LOXHD1 | lipoxygenase homology PLAT domains 1 | ORPHA:90636 |
| LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | ORPHA:90636 |
| MAP1B | microtubule associated protein 1B | ORPHA:90635 |
| MARVELD2 | MARVEL domain containing 2 | ORPHA:90636 |
| MCM2 | minichromosome maintenance complex component 2 | ORPHA:90635 |
| MET | MET proto-oncogene, receptor tyrosine kinase | ORPHA:90636 |
| MINAR2 | membrane integral NOTCH2 associated receptor 2 | ORPHA:90636 |
| MIR96 | microRNA 96 | ORPHA:90635 |
| MPZL2 | myelin protein zero like 2 | ORPHA:90636 |
| MSRB3 | methionine sulfoxide reductase B3 | ORPHA:90636 |
临床表型 13
常见 79–30%6
- 言语辨别异常 HP:0001963
- 语言发育迟缓 HP:0000750
- 学语后感音神经性听力受损 HP:0008596
- 学语前感音神经性听力受损 HP:0000399
- 极重度感音神经性听力受损 HP:0011476
- 渐进性感音神经性听力受损 HP:0000408
偶见 29–5%6
- 前庭眼反射异常 HP:0007670
- 儿童起病感音神经性听力受损 HP:0011474
- 传导性听力受损 HP:0000405
- 高频听力受损 HP:0005101
- 中度听力受损 HP:0012713
- 重度听力受损 HP:0012714
罕见 <4–1%1
- 低频感音神经性听力受损 HP:0008573
近两年的全球研究 97L2
2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。本病的检索词较宽泛,命中数可能偏高,请以标题为准。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-06Tonotopic specialization of MYO7A isoforms in auditory hair cells
- 2026-06开放获取HSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis
- 2026-06开放获取Situational analysis of health systems for ear and hearing care in the World Health Organization (WHO) Eastern Mediterranean Region: A systematic review and evidence synthesis to inform national policies and strategies
- 2026-05综述开放获取Connexin 26 in Hearing Health and Disease: StructuralFoundations, Mutation Mechanisms, and Therapeutic Perspectives
- 2026-05开放获取Comprehensive genotype-phenotype correlation analysis in 11 509 neonates carrying common deafness-associated pathogenic variants
- 2026-05开放获取Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness
- 2026-04开放获取Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer
- 2026-04综述开放获取Gasdermin family: a promising therapeutic target for asthma
- 2026-03开放获取Multi-omics and mendelian randomization uncover microbial-metabolite-gene interactions in age-related hearing loss
- 2026-03综述开放获取Multitarget protection by Chinese herbal medicines against sensorineural hearing loss: a focus on oxidative stress, apoptosis, and inflammation
- 2026-03系统综述开放获取A Systematic Review of Genes Affecting Endocochlear Potential
- 2026-03Vestibular function prior to cochlear implantation in patients with non-syndromic hearing loss caused by CDH23 mutations: a retrospective case series
- 2026-02开放获取Multidimensional analysis of screening results of deafness susceptibility genes in 3066 newborns of different altitudes and nationalities in Xining, Qinghai(ISRCTN89197487)
- 2026-02开放获取Abnormal iron homeostasis mediates cochlear hair cell impairment and hearing loss in Gprasp2-deficient mice
- 2026-02开放获取Genetic Diagnosis and Discovery Enabled by Large Language Models
- 2026-02综述开放获取Autophagy in Sensorineural Hearing Loss: Jekyll or Hyde?
- 2026-01开放获取Analysis of combined screening results of the hearing and deafness genes in 10,754 newborns
- 2026-01开放获取GJB2 c.109G > A mutation activating IFI27-mediated mitochondrial apoptosis pathway leading to hereditary non-syndromic hearing loss
- 2026-01开放获取P2X4 receptors as the dynamic regulators of auditory sensory cell activity: a potential new mechanism for protecting hearing?
- 2026-01病例报告开放获取Dual Genetic Diagnosis of Prader-Willi Syndrome and TMC1-Related Severe Congenital Hearing Loss: Diagnostic Challenges and Cochlear Implant Outcomes
中国境外的在招试验 2L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
共 2 项。
- 招募中NCT05402813Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes法国
- 招募中NCT01793168Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford澳大利亚、美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)